2017
DOI: 10.1371/journal.pone.0169916
|View full text |Cite
|
Sign up to set email alerts
|

Diversity and composition of vaginal microbiota of pregnant women at risk for transmitting Group B Streptococcus treated with intrapartum penicillin

Abstract: BackgroundAdministering intravenous antibiotics during labor to women at risk for transmitting Group B Streptococcus (GBS) can prevent infections in newborns. However, the impact of intrapartum antibiotic prophylaxis on mothers’ microbial community composition is largely unknown. We compared vaginal microbial composition in pregnant women experiencing preterm birth at ≤ 32 weeks gestation that received intrapartum antibiotic prophylaxis with that in controls.MethodsMicrobiota in vaginal swabs collected shortly… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
25
0

Year Published

2018
2018
2019
2019

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 22 publications
(26 citation statements)
references
References 36 publications
1
25
0
Order By: Relevance
“…Despite their widespread use, there are few published data on the potential effects of antibiotics on the infant and maternal microbiome during the process of labour and delivery at term gestation. [37][38][39][40][41][42][43][44] To our knowledge, no large cohort study has examined the effect of specific classes of antibiotics on the developing infant intestinal microbiota of full-term infants. This is relevant in practice because different classes of antibiotics are Figure 3.…”
Section: Main Findingsmentioning
confidence: 99%
See 1 more Smart Citation
“…Despite their widespread use, there are few published data on the potential effects of antibiotics on the infant and maternal microbiome during the process of labour and delivery at term gestation. [37][38][39][40][41][42][43][44] To our knowledge, no large cohort study has examined the effect of specific classes of antibiotics on the developing infant intestinal microbiota of full-term infants. This is relevant in practice because different classes of antibiotics are Figure 3.…”
Section: Main Findingsmentioning
confidence: 99%
“…This finding is similar to those of previous studies focused on the use of maternal antibiotics in general, particularly with the decrease in Bacteroides and Bifidobacterium. [38][39][40][41][42][43]46,47 One study 40 observed significant effects of GBS prophylaxis on the infant gut microbiome at 6 months among 150 pregnancies for members of Clostridiaceae, Ruminococcoceae and Enterococcaceae whereas another 41 (n = 83) found lower levels of Bifidobacterium and Escherichia at 12 weeks of life in infants of mothers exposed to intrapartum antibiotics.…”
Section: Main Findingsmentioning
confidence: 99%
“…Those subjects called hereinafter "non-spontaneous preterm" group, were used as a second control because they present a microbial community that might not be associated with spontaneous preterm delivery but have a better match in terms of gestational age with the spontaneous preterm group. All pregnant women sampled on this work had vaginal swab (Sterile Specimen Collection Swabs to collect specimens from soft tissue surfaces-Labor swab®) collected up to 4 hours before labor begins, as described by Roesch and colleagues [27]. Collected swab samples were stored at − 80°C until DNA extraction.…”
Section: Experimental Designmentioning
confidence: 99%
“…Microbial DNA extraction, 16S rRNA amplification and sequencing, and data processing Microbial DNA was extracted from frozen swab samples as previously described by Roesch et al [27]. All DNA samples were kept at − 20°C until use in PCR reactions.…”
Section: Experimental Designmentioning
confidence: 99%
“…Importantly, shifts in the gut microbiome across pregnancy can persist for at least 4 weeks postpartum (Koren et al, ), thus any perturbations such as the use of antibiotics can influence inflammation, dysregulate the gut‐brain‐axis, and potentiate the risk for adverse outcomes. Antibiotics administered during pregnancy have been shown to significantly decrease the presence of Lactobacillus , the dominant vaginal microbe that prevents infections by maintaining the microbial integrity of the vaginal environment (Khan et al, ; Miller, Beasley, Dunn, & Archie, ; Roesch et al, ). A shift in the abundance of vaginal Lactobacillus is not only more prevalent in women with bacterial infections, but also makes women more susceptible to bacterial infections (Kacerovsky et al, ) and increases the chances of receiving additional antibiotic therapy.…”
Section: Introductionmentioning
confidence: 99%